• Most absorbable form of quercetin
• Offers 40x higher absorption than regular quercetin
• Provides 167 mg of enzymatically modified isoquercitrin (EMIQ), providing 50 mg of quercetin, along with 50 mg of vitamin C per capsule
• Provides anti-inflammatory, antioxidant, anti-allergy, and cardiovascular benefits
• Suitable for vegetarians and vegans

Quercetin, a dietary flavonol known to be one of the most potent plant-derived antioxidants, has multiple biological actions, with preclinical studies showing anti-inflammatory, antithrombotic, and vasodilatory benefits. The limiting factor in quercetin's clinical effectiveness appears to be its poor bioavailability. Enzymatically modified isoquercitrin (EMIQ) is a quercetin monoglucoside and its alpha-oligoside mixture that has been shown to have significantly higher bioavailability than other available forms. In animals, EMIQ has been shown to produce a 40-fold increase in Cmax (peak plasma concentration) and an 18-fold increase in area under the curve compared to quercetin. In humans, EMIQ supplementation increased plasma concentrations to a significantly higher degree than other forms, including aglycone and isoquercitrin (Q3G) forms. Placebo-controlled randomized trials have shown EMIQ to have clinical benefits not seen with less absorbable forms. In a recent crossover trial in volunteers at risk for cardiovascular disease (i.e., with elevated blood pressure, lipids, glucose, or waist circumference), EMIQ improved endothelial function (as measured by flow-mediated dilation), a key risk factor for hypertension, atherosclerosis, and cardiovascular disease. American football players taking whey protein supplements experienced greater increases in lower-body muscle mass and antioxidant protection when consuming 42 mg of EMIQ per day compared to whey alone. Two trials found EMIQ to reduce medication use and eye symptoms of hay fever due to Japanese cedar pollinosis.